337 related articles for article (PubMed ID: 22448595)
1. The therapeutic potential of the endocannabinoid system for Alzheimer's disease.
Karl T; Cheng D; Garner B; Arnold JC
Expert Opin Ther Targets; 2012 Apr; 16(4):407-20. PubMed ID: 22448595
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer's disease.
Karl T; Garner B; Cheng D
Behav Pharmacol; 2017 Apr; 28(2 and 3-Spec Issue):142-160. PubMed ID: 27471947
[TBL] [Abstract][Full Text] [Related]
3. The role of the endocannabinoid system in Alzheimer's disease: facts and hypotheses.
Bisogno T; Di Marzo V
Curr Pharm Des; 2008; 14(23):2299-3305. PubMed ID: 18781980
[TBL] [Abstract][Full Text] [Related]
4. The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease.
Bedse G; Romano A; Lavecchia AM; Cassano T; Gaetani S
J Alzheimers Dis; 2015; 43(4):1115-36. PubMed ID: 25147120
[TBL] [Abstract][Full Text] [Related]
5. Targeting the endocannabinoid system in Alzheimer's disease.
Koppel J; Davies P
J Alzheimers Dis; 2008 Nov; 15(3):495-504. PubMed ID: 18997302
[TBL] [Abstract][Full Text] [Related]
6. Roles of Cannabidiol in the Treatment and Prevention of Alzheimer's Disease by Multi-target Actions.
Zhang XB; Li J; Gu J; Zeng YQ
Mini Rev Med Chem; 2022; 22(1):43-51. PubMed ID: 33797364
[TBL] [Abstract][Full Text] [Related]
7. Role of the endocannabinoid system in Alzheimer's disease: new perspectives.
Pazos MR; Núñez E; Benito C; Tolón RM; Romero J
Life Sci; 2004 Sep; 75(16):1907-15. PubMed ID: 15306158
[TBL] [Abstract][Full Text] [Related]
8. New and emerging treatments for Alzheimer's disease.
Corbett A; Ballard C
Expert Opin Emerg Drugs; 2012 Jun; 17(2):147-56. PubMed ID: 22439621
[TBL] [Abstract][Full Text] [Related]
9. Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes.
Bak AM; Egefjord L; Gejl M; Steffensen C; Stecher CW; Smidt K; Brock B; Rungby J
Expert Opin Ther Targets; 2011 Oct; 15(10):1153-62. PubMed ID: 21749267
[TBL] [Abstract][Full Text] [Related]
10. [Functional role of the endocannabinoid system in emotional homeostasis].
Marco EM; Viveros MP
Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
[TBL] [Abstract][Full Text] [Related]
11. Update on the endocannabinoid system as an anticancer target.
Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M
Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344
[TBL] [Abstract][Full Text] [Related]
12. [Glutamate-related excitotoxicity neuroprotection with memantine, an uncompetitive antagonist of NMDA-glutamate receptor, in Alzheimer's disease and vascular dementia].
Tanović A; Alfaro V
Rev Neurol; 2006 May 16-31; 42(10):607-16. PubMed ID: 16703529
[TBL] [Abstract][Full Text] [Related]
13. Drug delivery strategies for Alzheimer's disease treatment.
Di Stefano A; Iannitelli A; Laserra S; Sozio P
Expert Opin Drug Deliv; 2011 May; 8(5):581-603. PubMed ID: 21391862
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between the M
Thompson KJ; Tobin AB
Cell Signal; 2020 Jun; 70():109545. PubMed ID: 31978506
[TBL] [Abstract][Full Text] [Related]
15. Potential immunotargets for Alzheimer's disease treatment strategies.
Fernández PL; Britton GB; Rao KS
J Alzheimers Dis; 2013; 33(2):297-312. PubMed ID: 23001712
[TBL] [Abstract][Full Text] [Related]
16. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
17. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review.
Cooray R; Gupta V; Suphioglu C
Mol Neurobiol; 2020 Nov; 57(11):4878-4890. PubMed ID: 32813239
[TBL] [Abstract][Full Text] [Related]
18. The endocannabinoid system and Alzheimer's disease.
Benito C; Núñez E; Pazos MR; Tolón RM; Romero J
Mol Neurobiol; 2007 Aug; 36(1):75-81. PubMed ID: 17952652
[TBL] [Abstract][Full Text] [Related]
19. Current perspectives on pharmacotherapy of Alzheimer's disease.
Chopra K; Misra S; Kuhad A
Expert Opin Pharmacother; 2011 Feb; 12(3):335-50. PubMed ID: 21222549
[TBL] [Abstract][Full Text] [Related]
20. Potential therapeutic agents against Alzheimer's disease from natural sources.
Park SY
Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
